| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 07/07/2005 | WO2005061484A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005061467A2 Piperazine derivatives as bradykinin antagonists |
| 07/07/2005 | WO2005061462A2 Diaryl pyrazole derivatives and their use as neurokinin-3 receptor modulators |
| 07/07/2005 | WO2005061450A2 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | WO2005061442A1 Opioid receptor antagonists |
| 07/07/2005 | WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | WO2005060959A1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | WO2005047258A3 Methods and compositions for selectin inhibition |
| 07/07/2005 | WO2005047257A3 Methods and compositions for selectin inhibition |
| 07/07/2005 | WO2005042521A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 07/07/2005 | WO2005042498A3 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
| 07/07/2005 | WO2004048927A3 Second order nonlinear optical chromophores, polymers containing same, and electro-optic devices therefrom |
| 07/07/2005 | WO2003063771A3 N4-acylcytosine nucleosides for treatment of viral iinfections |
| 07/07/2005 | WO2003053360A3 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/07/2005 | US20050148777 (2R)-6-chloro-7-isobutyl-2-(trifluoromethyl)-2H-chromene-3-carboxylic acid; cyclooxygenase-2 mediated disorders |
| 07/07/2005 | US20050148650 protein kinase B activating agents for preventing or treating depression, PTSD, Parkinson's disease, Alzheimer's diseases, and the like; comprises for e.g. [1] 2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline |
| 07/07/2005 | US20050148638 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure |
| 07/07/2005 | US20050148636 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 07/07/2005 | US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals |
| 07/07/2005 | US20050148627 Benzopyran compounds for use in the treatment and prevention of inflammation related conditions |
| 07/07/2005 | US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/07/2005 | US20050148601 Neurokinin-3 receptor modulators: diaryl imidazole derivatives |
| 07/07/2005 | US20050148588 LFA-1 antagonist compounds |
| 07/07/2005 | US20050148586 Quinoxalinones |
| 07/07/2005 | US20050148581 Quinolines; 1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol; Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum; reduces the total length of treatment and the frequency of drug administration; multi-drug and antibiotic resistance |
| 07/07/2005 | US20050147904 Organophotoreceptor with charge transport material having a thiiranyl group |
| 07/07/2005 | DE10358539A1 Carbonsäureamidderivate Carboxamide |
| 07/07/2005 | CA2792483A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2550643A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | CA2549389A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2549009A1 Opioid receptor antagonists |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | CA2529314A1 Piperazine derivatives and methods of use |
| 07/06/2005 | EP1550913A1 Organophotoreceptor with charge transport material having a thiiranyl group |
| 07/06/2005 | EP1550856A2 Optical device for use in plasmon resonance |
| 07/06/2005 | EP1550668A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 07/06/2005 | EP1550660A1 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/06/2005 | EP1550657A1 Amine compounds and use thereof |
| 07/06/2005 | EP1549655A2 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 07/06/2005 | EP1549639A1 Sulphonamide derivatives as antipsychotic agents |
| 07/06/2005 | EP1549636A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 07/06/2005 | EP1549634A1 Novel substituted indoles |
| 07/06/2005 | EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 07/06/2005 | EP1549628A2 Method of preparing amino acid taxane derivatives and polymer conjugates containing the same |
| 07/06/2005 | EP1549627A1 1-phenylalkyl-piperazines |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1549316A1 INHIBITORS OF TFG&bgr; |
| 07/06/2005 | EP1549304A1 Heterocyclic amides and their use in treating thromboembolic diseases and tumors |
| 07/06/2005 | EP1373256B1 Ccr5 antagonists useful for treating aids |
| 07/06/2005 | CN1636001A 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
| 07/06/2005 | CN1635903A Protease inhibitors |
| 07/06/2005 | CN1635890A Neuroprotective 2-pyridinamine compositions and related methods |
| 07/06/2005 | CN1634893A 4, 5-disubstituted-1, 8-naphthoyl imide compounds and use thereof |
| 07/06/2005 | CN1209016C Fungicides |
| 07/05/2005 | US6914069 Pharmaceutically active compounds and methods of use |
| 07/05/2005 | US6914062 Pyrazinone derivatives |
| 07/05/2005 | CA2151377C Aminomethylindans, -benzofurans and -benzothiophenes |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058883A1 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 06/30/2005 | WO2005058881A1 Chemical compounds |
| 06/30/2005 | WO2005058876A1 Pyrazine derivatives as effective compounds against infectious diseases |
| 06/30/2005 | WO2005058857A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 06/30/2005 | WO2005058844A2 Novel compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions |
| 06/30/2005 | WO2005058843A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/30/2005 | WO2005058842A1 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them |
| 06/30/2005 | WO2005058839A1 Optically active carboxamides and use thereof to combat undesirable microorganisms |
| 06/30/2005 | WO2005058837A1 Benzazepine derivatives as histamine h3 antagonists |
| 06/30/2005 | WO2005058834A2 Quinolines useful in treating cardiovascular disease |
| 06/30/2005 | WO2005058833A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 06/30/2005 | WO2005058822A1 Substituted amino-cycloalkanes |
| 06/30/2005 | WO2005058821A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058328A1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
| 06/30/2005 | WO2005058311A1 Heterocyclic aspartyl protease inhibitors |
| 06/30/2005 | WO2005032493A8 Amide compounds as ion channel ligands and uses thereof |
| 06/30/2005 | WO2004100960A8 Anti-inflammatory phosphonate compounds |
| 06/30/2005 | WO2004096236A3 Immunomodulator phosphonate conjugates |
| 06/30/2005 | WO2004085388A3 Cyclic protein tyrosine kinase inhibitors |
| 06/30/2005 | WO2004055009A8 Novel compounds having selective inhibiting efect at gsk3 |
| 06/30/2005 | US20050143447 Mixing at least one nonaqueous, pharmaceutically acceptable solvent and a taxane compound |
| 06/30/2005 | US20050143446 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 06/30/2005 | US20050143440 Excellent hypoglycemic agents for treating hyperglycemia, dyslipidemia, hypercholesterolemia, noninsulin-dependent type II diabetes, obesity, glucose intolerance, cardiovascular diabetic complications; reduced side effects due to absence of serotonin reuptake inhibition; imidazoline receptor pathologies |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143423 Antiulcer; antisecretory; solubility, bioavailability; slow hydrolysis; full inhibition of acid secretion in oral therapy by prolonged presence in body; 1-(carboxythiophenesulfonyl)- 2-(substituted pyridylmethylsulfinyl) benzimidazoles; also with LANSOPRAZOLE, OMEPRAZOLE, PANTOPRAZOLE, or RABEPRAZOLE |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050143418 Pesticidal heterocycles |
| 06/30/2005 | US20050143408 Aporphine esters and their use in therapy |
| 06/30/2005 | US20050143405 Dipeptidyl peptidase inhibitors that lower plasma glucose; treatment and prophylaxis of diabetes, non-insulin dependent diabetes; 2-amino-3aminomethyl-4-phenylpyridines |
| 06/30/2005 | US20050143390 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/30/2005 | US20050143387 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | US20050143316 Hepatitis C virus inhibitors |
| 06/30/2005 | US20050139822 A series of aromatic rings carrying a linear alkylene chain substituted with a polar group, e.g., 5-ethyl-5'''-(10-undecenyl)-2,2':5',2'':5'',2'''-quaterthiophene; thin films having the function of a dielectric layer and of a semiconductive layer; a self-assembled molecule (SAMS); low surface voltage |
| 06/30/2005 | US20050139814 Benzofuran and benzothiophene derivatives useful in the treatmint of hyper-proliferative disorders |
| 06/30/2005 | CA2551944A1 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 06/30/2005 | CA2550053A1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
| 06/30/2005 | CA2549821A1 Optically active carboxamides and use thereof to combat undesirable microorganisms |